Fresenius SE & Co KGaA (FRA:FRE) Given a €58.40 Price Target by JPMorgan Chase & Co. Analysts

JPMorgan Chase & Co. set a €58.40 ($67.91) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a report released on Thursday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Several other research firms have also weighed in on FRE. Warburg Research set a €65.00 ($75.58) price objective on Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Friday, July 26th. DZ Bank reaffirmed a buy rating on shares of Fresenius SE & Co KGaA in a research note on Wednesday, July 31st. Nord/LB set a €58.00 ($67.44) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Wednesday, July 31st. Independent Research set a €51.00 ($59.30) target price on Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Friday, August 2nd. Finally, Berenberg Bank set a €74.80 ($86.98) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Monday, August 12th. Nine equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of €57.93 ($67.36).

FRA:FRE opened at €43.37 ($50.42) on Thursday. The stock’s 50-day simple moving average is €43.63 and its 200 day simple moving average is €46.49. Fresenius SE & Co KGaA has a twelve month low of €60.16 ($69.95) and a twelve month high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

See Also: Current Ratio

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.